CANBRIDGE-B Shares Climb Over 4% Following Completion of Share Placement to WuXi Biologics Unit

Stock News03-13 14:48

CANBRIDGE-B (01228) saw its shares rise more than 4% in the afternoon session. At the time of writing, the stock was up 4%, trading at HK$2.6 with a turnover of HK$1.5938 million. The movement follows the company's announcement of the completion of issuing a total of 84.0336 million subscription shares. CANBRIDGE-B had previously disclosed the placement of shares to a subsidiary of WuXi Biologics (02269). Upon completion of the placement, WuXi Biologics' stake in CANBRIDGE-B will increase to approximately 16.27%. According to the announcement, the net proceeds from the share placement amount to approximately HK$199 million. About 12% of the funds will be allocated for working capital and registration maintenance of commercialized products, 28% will be used for research and development expenses of the existing product pipeline, and 60% will be utilized to settle the group's trade payables.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment